ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences
| ALIMDelisted Stock | USD 5.54 0.01 0.18% |
About 61% of Alimera Sciences' investor base is looking to short. The analysis of current outlook of investing in Alimera Sciences suggests that many traders are alarmed regarding Alimera Sciences' prospects. Alimera Sciences' investing sentiment overview a quick insight into current market opportunities from investing in Alimera Sciences. Many technical investors use Alimera Sciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Alimera |
PRINCETON, N.J., Sept. 10, 2024 -- ANI Pharmaceuticals, Inc. today provided an update on the status of the completion of its previously announced acquisition of Alimera Sciences, Inc. . We note the Alimera press release issued today. The Company continues to work in good faith toward closing of the acquisition. Any delay is a result of discussions regarding closing conditions, which the Company expects to resolve
Read at finance.yahoo.com
 |
Alimera Sciences Fundamental Analysis
We analyze Alimera Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alimera Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alimera Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Alimera Sciences is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Alimera Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alimera Sciences stock to make a market-neutral strategy. Peer analysis of Alimera Sciences could also be used in its relative valuation, which is a method of valuing Alimera Sciences by comparing valuation metrics with similar companies.
Peers
Alimera Sciences Related Equities
| PTPI | Petros Pharmaceuticals | 12.90 | ||||
| CPHI | China Pharma | 10.53 | ||||
| CYTH | Cyclo Therapeutics | 5.26 | ||||
| ORGO | Organogenesis Holdings | 2.74 | ||||
| LFCR | Lifecore Biomedical | 2.80 | ||||
| DERM | Journey Medical | 4.58 | ||||
| SXTC | China SXT | 6.67 | ||||
| SHPH | Shuttle Pharmaceuticals | 7.50 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Alimera Stock
If you are still planning to invest in Alimera Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alimera Sciences' history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |